Paradigm Biopharmaceuticals (PAR) | Bell Potter Healthcare Conference 2025
Paul Rennie, Managing Director at Paradigm Biopharmaceuticals (PAR) presents at the Bell Potter Healthcare Conference 2025.
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be sent privately to Paradigm Biopharmaceuticals. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Paradigm Biopharmaceuticals a question about this update.